Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M.K. Schuler
Observed name:
M. Schuler
Institutions:
National Center for Tumor Diseases,
Essen University Hospital,
Stiftung Oskar Helene Heim,
University Hospital Carl Gustav Carus,
University of Duisburg-Essen
Observed institutions:
National Center for Tumor Diseases,
Essen University Hospital,
Stiftung Oskar Helene Heim,
University Hospital Carl Gustav Carus,
University of Duisburg-Essen
OpenAlex ID:
A5123017356
Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care
2026
·
L. Sellmann
, D. Marschner
, et al.
·
ESMO Real World Data and Digital Oncology
·
2
PDF
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre
2026
·
S. Elbasan
, S. Kasper
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
Long-term impact of sporadic desmoid fibromatosis on work life, reproductive health, and support needs: results from the PROSa-DES study
2026
·
S.A. Zapata Bonilla
, R. Hoffmann
, et al.
·
ESMO rare cancers.
Show more works
View as search
Works count:
4
Citation count:
4
H-index:
2
I10-index:
Year
Topic
Type